Fusion Scans
Back

IMGN

NASDAQ
Immunogen Inc · Healthcare · Biotechnology
Loading quote…

Highlights

Market Cap
$8.72B
PE Ratio
EV to Ebitda
Earnings Yield
-1.05%
Revenue (TTM)
$287.6M
Net Income (TTM)
$-73.5M
Revenue (Annual YoY Growth)
55.72%
Revenue (Quarterly YoY Growth)
637.72%
Profit Margin
-25.56%
Return on Equity
-24.37%
Debt to Equity Ratio
0.1284
Dividend Yield
0.00%

All fundamentals

Core10 fields
Market Cap$8.72B
Revenue TTM$287.6M
Shares Outstanding266.3M
Float247846774
Float Short6.77%
Days To Cover2.8911
Short Interest18855805.0
Insider Ownership0.94%
Relative Strength97.9
GARP2968
Growth Estimates6 fields
Revenue Growth (Annual)55.72%
Revenue Growth (Quarterly YoY)637.72%
Operating Revenue Growth (Annual)0.557232
Operating Revenue Growth (Quarterly YoY)6.377236
3-Year Revenue Growth9.76%
5-Year Revenue Growth-1.18%
Operations28 fields
Revenue TTM$287.6M
Gross Margin TTM98.66%
Gross Margin (Quarterly)98.10%
R&D % of Revenue TTM72.23%
R&D Expenses TTM$207.8M
Operating Margin TTM-27.88%
Operating Margin (Quarterly)22.88%
Operating Expenses TTM$363.9M
Profit Margin TTM-25.56%
Profit Margin (Quarterly)27.11%
Net Income TTM$-73.5M
EPS TTM-0.31
EPS (Quarterly)0.1
EBIT Margin TTM-21.83%
EBIT Margin (Quarterly)29.25%
EBITDA Margin TTM-21.23%
EBITDA Margin (Quarterly)29.62%
EBITDA TTM$-61.1M
CFO % of Revenue TTM-211.25%
CFO % of Revenue (Quarterly)2.44%
CFO TTM$-197.9M
Cash Margin-69.43%
Capex % of Revenue TTM0.66%
Capital Expenditures$1.9M
FCF % of Revenue TTM-212.50%
FCF % of Revenue (Quarterly)1.25%
FCF TTM$-199.8M
Fundamental Score5
Efficiency6 fields
ROE-24.37%
ROA-14.52%
ROIC-22.25%
CROCI-60.46%
Stock Comp % (Quarterly)6.94%
Stock Comp % TTM23.55%
Valuation14 fields
P/E Forward82.0239
P/S Forward14.3758
EV/EBITDA Forward75.1641
EV/Revenues (TTM)25.3537
EV/Revenues Forward13.3959
EV/CFO-18.624
EV/FCF (TTM)-36.5009
Price To Book13.9344
Price to Tangible Book2.5762
Earnings Yield-1.05%
FCF Yield-2.55%
Dividend Yield0.00%
Payout Ratio0.00%
Value Score1
Relative to Industry5 fields
Relative Gross Margin (Quarterly)1.3354
Relative P/S2.7888
Relative P/B2.5643
Relative Dividend Yield0
Relative Debt to Equity0.3011
Liquidity11 fields
Cash Per Share2.2778
Current Ratio5.6951
Cash & ST Assets$605.5M
Total Debt$72.1M
Total Assets$822.1M
Total Liabilities$260.5M
Shareholders Equity$561.6M
Debt to Equity0.1284
Debt to Assets8.77%
CFO to Debt (TTM)-6.8678
Debt to EBITDA (TTM)-0.472
Yields3 fields
Dividend Yield0.00%
Payout Ratio0.00%
Earnings Yield-1.05%
Options Flow8 fields
Call Volume8386
Put Volume1044
Put/Call Ratio0.1244932029573098
Call $ Volume1531851
Put $ Volume87293
Put/Call $ Ratio0.056985307317748264
Call OI28907
Put OI70891

News AI summary

Past 90 days of news, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Press release AI summary

Past 90 days of press releases, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Income statement AI analysis

Recent quarterly income statements with margin trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Balance sheet AI analysis

Recent quarterly balance sheets with leverage trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Cash flow AI analysis

Recent quarterly cash flow statements with FCF trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.